Evidence map›Paper›PMID 27534971›Full record

ArticleMolecular imaging and biology2016

Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.

D L Bailey, B J Pichler, B Gückel, H Barthel, A J Beer, R Botnar, R Gillies, V Goh, M Gotthardt, R J Hicks and 17 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system.European journal of nuclear medicine and molecular imaging · 2021
    Article
  4. State of the art ofClinical and translational imaging · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Updates on the Role of Imaging in Cardiac Sarcoidosis.Current treatment options in cardiovascular medicine · 2018
    Review
  14. Review
  15. Article
  16. Review
  17. The need of standardization and of large clinical studies in an emerging indication of [European journal of nuclear medicine and molecular imaging · 2017
    Article
  18. History and future technical innovation in positron emission tomography.Journal of medical imaging (Bellingham, Wash.) · 2017
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

D L BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, and Faculty of Health Sciences, University of Sydney, Sydney, Australia.
B J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls-Universität, Tübingen, Germany.
B GückelDepartment of Interventional and Diagnostic Radiology, Eberhard-Karls-Universität, Tübingen, Germany.
H BarthelDepartment of Nuclear Medicine, University Clinic, Leipzig, Germany.
A J BeerDepartment of Nuclear Medicine, Ulm University, Ulm, Germany.
R BotnarDivision of Imaging Sciences and Biomedical Engineering, King's College London, London, UK.
R GilliesMoffitt Cancer Center, Tampa, USA.
V GohDivision of Imaging Sciences and Biomedical Engineering, Department of Cancer Imaging, King's College London, London, UK.
M GotthardtDepartment of Nuclear Medicine, Radboud University, Nijmegen, The Netherlands.
R J HicksPeter MacCallum Cancer Centre, Melbourne, Australia.
R LanzenbergerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
C la FougereDivision of Nuclear Medicine and clinical Molecular Imaging, Department of Radiology, University of Tübingen, Tübingen, Germany.
M LentschigZEMODI, Zentrum für Moderne Diagnostik, Bremen, Germany.
S G NekollaDepartment of Nuclear Medicine, Technical University Munich, Munich, Germany.
T NiederdraenkStrategy and Innovation Technology Center, Siemens Healthcare GmbH, Erlangen, Germany.
K NikolaouDepartment of Interventional and Diagnostic Radiology, Eberhard-Karls-Universität, Tübingen, Germany.
J NuytsDepartment of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven - University of Leuven, Leuven, Belgium.
D OlegoPhilips, 3000 Minuteman Road, Andover, MA, 01810, USA.
K Åhlström RiklundDepartment of Diagnostic Radiology, Radiation Sciences, Umeå University/Norrlands University Hospital, Umeå, Sweden.
A SignoreNuclear Medicine Unit, Departments of Medical-Surgical Sciences and Translational Medicine, "Sapienza" University of Rome, Rome, Italy.
M SchäfersDepartment of Nuclear Medicine, University Hospital Münster and European Institute for Molecular Imaging, University of Münster, Münster, Germany.
V SossiDepartment of Physics and Astronomy, University of British Columbia, Vancouver, Canada.
M SuminskiGE Healthcare, PET/MR, Milwaukee, USA.
P Veit-HaibachDepartment of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
L UmutluDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
M WissmeyerDepartment of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland.
T BeyerCenter for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University Vienna, 4L, Waehringer Guertel 18-20, 1090, Vienna, Austria. thomas.beyer@meduniwien.ac.at.

Funding

Cancer Research UK 16463Cancer Research UK 20000
6 · The paper itself

Abstract

This article provides a collaborative perspective of the discussions and conclusions from the fifth international workshop of combined positron emission tomorgraphy (PET)/magnetic resonance imaging (MRI) that was held in Tübingen, Germany, from February 15 to 19, 2016. Specifically, we summarise the second part of the workshop made up of invited presentations from active researchers in the field of PET/MRI and associated fields augmented by round table discussions and dialogue boards with specific topics. This year, this included practical advice as to possible approaches to moving PET/MRI into clinical routine, the use of PET/MRI in brain receptor imaging, in assessing cardiovascular diseases, cancer, infection, and inflammatory diseases. To address perceived challenges still remaining to innovatively integrate PET and MRI system technologies, a dedicated round table session brought together key representatives from industry and academia who were engaged with either the conceptualisation or early adoption of hybrid PET/MRI systems. Discussions during the workshop highlighted that emerging unique applications of PET/MRI such as the ability to provide multi-parametric quantitative and visual information which will enable not only overall disease detection but also disease characterisation would eventually be regarded as compelling arguments for the adoption of PET/MR. However, as indicated by previous workshops, evidence in favour of this observation is only growing slowly, mainly due to the ongoing inability to pool data cohorts from independent trials as well as different systems and sites. The participants emphasised that moving from status quo to status go entails the need to adopt standardised imaging procedures and the readiness to act together prospectively across multiple PET/MRI sites and vendors.

Indexed as

Magnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyAnimalsDiseaseGermanyHumansAttenuation correctionCardiologyCombined imagingMolecular imagingMRIMulti-parametric imagingNeurologyOncologyPETPET/CTPET/MRIQuantification

Identifiers

PMID27534971
PMCPMC5010606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.